Krajmalnik-Brown team and collaborators will lead a new study examining a novel treatment for gastrointestinal problems in children with autism. This research study has been approved by the U.S. Food and Drug Administration (FDA).
Biodesign Institute and ASU News are running an article on our research on this future study. The article was written by journalist Joe Caspermeyer, from Biodesign Institute.
Read full article on Biodesign Institute and ASU News Science & Tech web.